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Lymphocyte function-associated antigen-1 (LFA-1) is a heterodimeric integrin consisting of
αL (gene name, Itgal ) and β2 (gene name, Itgb2) subunits expressed in all leukocytes. LFA-1
is essential for neutrophil recruitment to inﬂamed tissue. Activation of LFA-1 by chemokines
allows neutrophils and other leukocytes to undergo arrest, resulting in ﬁrm adhesion on
endothelia expressing intercellular adhesion molecules (ICAMs). In mice, CXCR2 is the
primary chemokine receptor involved in triggering neutrophil arrest, and it does so through
“inside-out” activation of LFA-1. CXCR2 signaling induces changes in LFA-1 conformation
that are coupled to afﬁnity upregulation of the ligand-binding headpiece (extended with
open I domain). Unlike naïve lymphocytes, engagement of P-selectin glycoprotein ligand-1
(PSGL-1) on neutrophils stimulates a slow rolling behavior that is mediated by LFA-1 in a
distinct activation state (extended with closed I domain). How inside-out signaling cas-
cades regulate the structure and function of LFA-1 is being studied using ﬂow chambers,
intravital microscopy, and ﬂow cytometry for ligand and reporter antibody binding. Here,
we review how LFA-1 activation is regulated by cellular signaling and ligand binding. Two
FERM domain-containing proteins, talin-1 and Kindlin-3, are critical integrin co-activators
and have distinct roles in the induction of LFA-1 conformational rearrangements.This review
integrates these new results into existing models of LFA-1 activation.
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LFA-1 STRUCTURE, FUNCTION, AND INSIDE-OUT
ACTIVATION
Twenty-four different integrins are expressed in humans, each
composed of non-covalently associated α and β chains (Hynes,
2002). Integrins have large extracellular domains, single-pass
transmembrane segments, and short intracellular tails. Lacking
enzymatic activity, the short integrin cytoplasmic domains serve as
scaffolds for signaling and structural proteins that allow integrins
to be a conduit of bidirectional communication between the cyto-
plasm and extracellular ligands (Legate and Fassler, 2009; Moser
et al., 2009b) [Box 1]. The integrin ligand recognition site spans
the β subunit inserted-like (βI) domain and α subunit β-propeller
domain or, for about half of the integrin family, resides entirely
within theα subunit I (αI) domain (Lu et al., 2001; Luo et al., 2007).
All β2 integrins, including LFA-1 (αLβ2 or CD11a/CD18) [Box 2],
contain this extra αI domain within the headpiece. The structural
features of the various domains of LFA-1 have been reviewed in
great detail elsewhere (Luo et al., 2007).
The macromolecular structure of integrins is coupled to the
accessibility of the ligand-binding pocket and to its ligand-
binding afﬁnity. Therefore, the regulation of integrin confor-
mation is critical for their adhesive and signaling function (Luo
et al., 2007). Studies employing crystallography (Shimaoka et al.,
2003b), nuclearmagnetic resonance (Huth et al., 2000; Legge et al.,
2000), electron microscopy (Nishida et al., 2006), and molec-
ular dynamics simulation (Jin et al., 2004) have suggested that
LFA-1 can assume at least three distinct conformational states
(Figure 1). In its inactive state, the LFA-1 extracellular domain
has a bent structure shaped like an inverted V (Nishida et al.,
2006) with the low afﬁnity headpiece closely approaching the
plasma membrane (Larson et al., 2005; Nishida et al., 2006), simi-
lar to what has been shown for other integrins (Xiong et al., 2001;
Chigaev et al., 2003; Zhu et al., 2008; Xie et al., 2010). The inac-
tive state is also characterized by inter-domain contacts between
the N-terminal headpiece and membrane-proximal lower legs,
between the lower legs of the α and β chains, and between the
α and β transmembrane domains (TMDs; Takagi et al., 2002;
Li et al., 2005; Luo et al., 2005; Partridge et al., 2005; Nishida et al.,
2006). Based primarily on mutational studies, it is thought that
close association of TMDs stabilizes the inactive state and dis-
ruption of this association leads to integrin activation (Hughes
et al., 1996; Lu and Springer, 1997; Vinogradova et al., 2002;
Luo et al., 2005).
In contrast to the compact structure of inactive LFA-1, active
LFA-1 conformations exhibit an extended extracellular domain
with the ligand-binding headpiece situated more than 20 nm
above the membrane (Nishida et al., 2006). Extended structures
of LFA-1 (Figure 1) differ in the conformation of the headpiece
and αI domain, the angle between the βI domain and hybrid
domain into which the βI is inserted, and the distance between
the αL and β2 TMDs in the plane of the plasma membrane.
The extended ectodomain with a closed headpiece has also been
termed the “intermediate afﬁnity state” integrin (Luo et al., 2007).
It is thought that the spatial orientation of the headpiece alone
in the extended intermediate afﬁnity structure may account for
enhanced recognition of ligands, as steric hinderance may pre-
vent large, immobilized ligands from accessing the αI domain
in the bent, inactive LFA-1 conformer. This idea is supported
by data showing that the isolated LFA-1 αI domain alone, in its
basal state, can mediate transient interactions with intercellular
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BOX 1 | “Inside-out” and “outside-in” signaling.
Inside-out signaling refers to a process by which a cellular stimulus,
for example, a chemokine binding to its receptor, leads to integrin
activation by intracellular signaling pathways. Inside-out signaling
leads to vast conformational changes in integrins, but not directly
to clustering (redistribution of integrin heterodimers in the plane of
the plasma membrane). By contrast, outside-in activation refers to
integrin activation induced by ligand binding. Although the terminol-
ogy is often confused, outside-in signaling, distinct from outside-in
activation, refers to a process whereby the cell receives signals
from the extracellular environment through integrins that have
already been activated and are now bound to immobilized ligands
on another cell or in the extracellular matrix. Adhesion strengthen-
ing, or stabilization, is a process following integrin activation and
initial ligand binding. Adhesion strengthening most likely involves
integrin clustering and is required to keep arrested leukocytes from
being washed away.
BOX 2 | β2 integrin family.
The β2 subfamily of integrins comprises four heterodimers. αLβ2
(LFA-1, CD11a/CD18) is expressed on all leukocytes; αMβ2 (Mac-1,
CD11b/CD18) is expressed on granulocytes, monocytes, macro-
phages, and subsets of activated lymphocytes; αXβ2 (P150,95,
CD11c/CD18) is expressed on dendritic cells, macrophages, and
small subsets of blood monocytes; and αDβ2 (CD11d/CD18) is
expressed on tissue-speciﬁc subsets of macrophages.
adhesion molecule-1 (ICAM-1) that result in a rolling pheno-
type (Knorr and Dustin, 1997; Eniola et al., 2005), whereas the
full-length LFA-1 molecule does not support interaction under
ﬂow conditions (Salas et al., 2002). However, in a series of
disulﬁde-stabilized crystal structures of the αL I domain, dis-
tinct conformations with low, intermediate, and high afﬁnity were
identiﬁed, where the transition from low to intermediate afﬁnity
was mainly driven by an increase in the bimolecular association
rate (kon) and the transition from intermediate to high afﬁnity
was mainly driven by lower koff (slower release of bound lig-
and; Shimaoka et al., 2003b). Notably, the αI metal ion-dependent
adhesion site (MIDAS) that recognizes ligand retains the same
coordination and conformation in the putative αI low and inter-
mediate afﬁnity conformations. Therefore, in addition to the
macromolecular integrin structures, it is apparent that the αI
domain may exist in three distinct conformations regulated by
the relative position of the α7 helix. There is ample evidence,
as will be discussed below, that extended LFA-1 mediates neu-
trophil slow rolling by transiently binding to ICAM-1. During
slow rolling, the αL I domain is most likely not in the high afﬁnity
conformation.
In the “high afﬁnity state” structure, swingout of the hybrid
domain away from the α subunit by approximately 60◦ is coupled
to opening of the headpiece through the downward movement
of the αI domain α7 helix that connects to the βI domain as an
internal ligand for the βI MIDAS (Alonso et al., 2002; Xiao et al.,
2004; Luo et al., 2007). This shift in the α7 helix is coupled to
rearrangement of the αI domain, enhancing its afﬁnity for ligand
(Alonso et al., 2002; Yang et al., 2004). It is the high afﬁnity LFA-1
conformer that mediates arrest of leukocytes on the endothe-
lium (Constantin et al., 2000; Giagulli et al., 2004), and in vitro
studies demonstrate that the open headpiece of LFA-1 is neces-
sary and sufﬁcient to mediate cell arrest under ﬂow conditions
(Salas et al., 2002, 2004).
The structure and afﬁnity of integrin receptors is thought to be
regulated by cells in an “inside-out”manner [Box 1] through sig-
naling cascades that impinge upon the integrin cytoplasmic tails
(Dustin and Springer, 1989; O’Toole et al., 1990; Sims et al., 1991).
Two intracellular protein families have been implicated in the ﬁnal
events of integrin activation. Talins and Kindlins both contain a
FIGURE 1 | LFA-1 conformations. Integrin function is structurally regulated
and three distinct conformations have been demonstrated. In its low afﬁnity
state (left), LFA-1 is compact with a sharp bend at the “genu” and headpiece
closely approaching the plasma membrane. Extended conformations (middle)
differ in the orientation of their hybrid domain (purple), with swingout of this
domain representing a conversion from intermediate to high afﬁnity state
(right). Data suggest that the extended/closed conformation (middle) can have
either a low or intermediate afﬁnity αI domain.
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band 4.1/ezrin/radixin/moesin (FERM) domain with four inde-
pendently folded subdomains (F0–F3; Moser et al., 2009b). While
the FERM domain comprises the talin head that is sufﬁcient
for activating integrins (Calderwood et al., 1999; Ye et al., 2010),
talins also have a ﬂexible rod domain that contains actin-binding
sequences and mediates cytoskeletal association (Critchley, 2009).
Although many of the structural and functional studies that have
dissected the role of talin in integrin activation have employed
experimental systems where the talin head domain alone is used,
the full-length molecule exists in a basal autoinhibited state that
is mediated by contact between the integrin-binding F3 subdo-
main and rod domain (Goksoy et al., 2008). Binding to phos-
pholipids, such as phosphatidylinositol 4,5-bisphosphate (PIP2),
relieves this autoinhibition and activates talin for integrin binding
(Martel et al., 2001; Goksoy et al., 2008). The ability of talins and
Kindlins to activate integrins depends on their binding to mem-
brane phospholipids. For talin, this occurs through positively
charged surfaces within the F1, F2, and F3 subdomains (Anthis
et al., 2009; Goult et al., 2010). Kindlins have an analogous sur-
face within the F1 subdomain (Bouaouina et al., 2012) as well as
an additional pleckstrin homology domain that is inserted within
its F2 subdomain (Tu et al., 2003; Qu et al., 2011), both of which
bind to membrane phospholipids and are important for integrin
activation.
Talins and Kindlins mediate integrin activation by binding
directly to separate NXX(Y/F) motifs within the integrin β chain
short cytoplasmic tail (Tadokoro et al., 2003; Harburger et al.,
2009). Multiple lines of evidence demonstrate that talins con-
tribute to the separation of the integrin TMDs (Kim et al., 2003;
Wegener et al., 2007), but the mechanisms by which Kindlins are
involved in regulating integrin conformation are largely unknown
(Moser et al., 2009b; Shattil et al., 2010). Mutations of Kindlin-3,
the Kindlin isoform expressed in hematopoietic cells, were found
to underlie the leukocyte adhesion deﬁciency type III (LAD-III)
pathology (Malinin et al., 2009; Moser et al., 2009a; Svensson et al.,
2009) [Box 3]. Kindlin-3-deﬁcient leukocytes are unable to arrest
on inﬂamed endothelium, but their selectin-mediated rolling
capacity is normal, indicating an important role for Kindlin-3
in LFA-1 activation (Moser et al., 2009a). The roles of talin-1
and Kindlin-3 in regulating LFA-1 in neutrophils are discussed
in further detail below.
MODELS OF LFA-1 ACTIVATION
There are several models of integrin activation by inside-out
signaling. The dynamic equilibrium that exists between the var-
ious integrin conformational states (Figure 1) appears to vary
between the 24 different integrin subtypes and even amongst the
four different β2 integrins (Nishida et al., 2006). Therefore, aside
from the most basic structural commonalities, integrin activation
mechanisms may exhibit signiﬁcant variability.
The switchblade model of integrin activation stems from the
delineation of the three distinct afﬁnity states described above,
and was formulated based on crystallography (Xiong et al., 2001;
Xiao et al., 2004) and studies of isolated integrins by electron
microscopy (Takagi et al., 2002; Nishida et al., 2006). The switch-
blade model postulates that only the closed, unliganded integrin
headpiece can stably exist in the overall bent structure. The
BOX 3 | Leukocyte adhesion deficiency type III.
In the human disease leukocyte adhesion deﬁciency type III (LAD-
III), activation of β2, β3, and some β1 integrins is defective. LAD-III
was discovered in 1997 and initially called LAD-I variant (Kuijpers
et al., 1997). Kuijpers and colleagues recognized that expression of
β2 integrins was normal but their activation was defective in these
patients (Alon et al., 2003; Alon and Etzioni, 2003; Malinin et al.,
2009; Manevich-Mendelson et al., 2009; Svensson et al., 2009;
Jurk et al., 2010; McDowall et al., 2010; Robert et al., 2011). Alon
and colleagues (Pasvolsky et al., 2007) reported a point mutation
in RASGRP2, the gene encoding CalDAG-GEFI, and thought that
defective CalDAG-GEFI caused LAD-III. This idea was supported
by the leukocyte and platelet adhesion deﬁciencies exhibited by
CalDAG-GEFI knockout mice (Bergmeier et al., 2007). However,
it was later found that mutation of the FERMT3 gene encoding
Kindlin-3 that causes the pathology of LAD-III (Kuijpers et al., 2009;
Svensson et al., 2009), dominates the phenotype of the subset of
LAD-III patients with mutations in both FERMT3 and RASGRP2.
Humans deﬁcient in CalDAG-GEFI, but not Kindlin-3, have not been
described. There is now consensus that mutations in the FERMT3
gene encoding kindlin-3 cause all known LAD-III cases (Abram and
Lowell, 2009).
switchblade-like extension of the extracellular domain occurs as
a result of disruption of headpiece-lower leg and α/β lower leg
stabilizing contacts, either by separation of the TMDs or by
ligand-induced hybrid domain swingout (Luo et al., 2007). The
switchblade model received support from the recent ﬁnding that
single, full-length αIIbβ3 integrin embedded in membrane has the
same compact structure observed in isolated extracellular domains
and can undergo ectodomain extension in the presence of talin
head domain bound to the integrin cytoplasmic tail (Ye et al.,
2010). Most of the activated structures observed in this study,
however, resembled the intermediate rather than the high afﬁnity
conformation. As discussed below, an important unresolved ques-
tion is whether inside-out signaling alone (that is, in the absence
of ligand binding) induces the high afﬁnity structure with an open
headpiece.
The deadboltmodel of integrin activationwas proposed (Xiong
et al., 2003) based on the observation that crystals of the unbound
(Xiong et al., 2001) and ligand-occupied (Xiong et al., 2002) inte-
grin αVβ3 exhibited the same compact, bent structure. The crystal
structure of ligand-occupied, bent αVβ3 was further supported
by electron microscopy studies (Adair et al., 2005). In addition,
FRET studies have shown that small ligand binding to α4β1 inte-
grin (VLA-4) on the living cell surface can occur in the absence of
ectodomain extension (Chigaev et al., 2007). The deadbolt model
posits that a loop within the β subunit extracellular membrane-
proximal β-tail domain contacts the α7 helix of the βI domain that
regulates its conformation and afﬁnity (Xiong et al., 2003). During
activation, movement of the TMDs would disrupt the deadbolt
and allow headpiece opening in the bent structure (Xiong et al.,
2003). However, elimination of the β-tail domain loop that was
proposed to form the deadbolt did not enhance ligand binding
(Zhu et al., 2007).
More recent work suggests that inside-out integrin activation
is more complicated than the switchblade and deadbolt models
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imply. For example, in kinetic studies of VLA-4 on live cells, bind-
ing of antibodies that recognize epitopes selectively exposed in
extended integrin structures was minimal after triggering two dif-
ferent physiologic inside-out activation pathways, but was robust
in the presence of a small ligand even without cell stimulation
(Chigaev et al., 2009). The same group recently performed similar
experiments with a ﬂuorescent ligand probe of LFA-1 and found
that small ligand binding to LFA-1 in the absence of inside-out
activationwas very slow (Chigaev et al., 2011). These ﬁndings indi-
cate a greater restraint on inactive LFA-1 compared to VLA-4 with
respect to ligand binding. Inside-out stimulation via chemokine
or formyl peptide receptors [both G-protein coupled receptors
(GPCRs)] rapidly enhanced LFA-1 small ligand binding, suggest-
ing afﬁnity upregulation of the headpiece. These studies suggest
that mechanisms of integrin conformational regulation, including
inside-out and ligand-induced outside-in activation, have both
shared and distinct components between integrin subtypes and
activating stimuli.
It is clear that inside-out signal transduction pathways, such
as those elicited by chemokine receptor engagement, stimulate
an increase in the afﬁnity of integrins. The ability of LFA-1 to
bind ICAM-1 in its soluble, rather than immobilized, form has
been utilized as a sensitive assay that speciﬁcally reports the high
afﬁnity state (Constantin et al., 2000; Shimaoka et al., 2003a,b).
Further support for this assay as a means to discriminate between
extended/closed and extended/open conformations of LFA-1 was
provided by Laudanna and colleagues (Bolomini-Vittori et al.,
2009) by showing that a signaling defect in headpiece opening due
to silencing of phosphatidylinositol-4-phosphate 5-kinase type
I gamma (PIP5KC) blocks chemokine-induced soluble ICAM-1
binding to T lymphocytes despite the ability of LFA-1 to become
extended (as indicated by a reporter mAb) under the same con-
ditions. Many studies have thus demonstrated that chemokines
induce a high afﬁnity state of LFA-1 that is competent for sol-
uble ICAM-1 binding and that mediates T lymphocyte arrest
(Constantin et al., 2000; Giagulli et al., 2004; Bolomini-Vittori
et al., 2009).
Despite these extensive studies, it is not clear whether
chemokine stimulation alone, in the absence of ligand, trig-
gers opening of the LFA-1 headpiece. Chemokines induce the
binding of epitope-speciﬁc reporter antibodies, such as mAb 24
(Dransﬁeld et al., 1992) and 327C mAb (Beals et al., 2001), that
speciﬁcally recognize the extended/open high afﬁnity conforma-
tion of LFA-1 (Bolomini-Vittori et al., 2009). However, these
reporter antibodies also recognize ICAM-1-bound LFA-1 in the
absence of cellular stimulation (Beals et al., 2001). Therefore, it
remains possible that chemokines enhance the afﬁnity of LFA-1
for ICAM-1 and permit a transition to the high afﬁnity state, but
do not directly induce opening of the headpiece associated with
the high afﬁnity αI domain. Rather, ligand engagement and a
force pulling on the engaged integrin may subsequently be needed
for LFA-1 to achieve its high afﬁnity state. Afﬁnity measure-
ments of LFA-1 on the cell surface show that inside-out signaling
in response to stromal cell-derived factor-1 (SDF-1, also known
as chemokine CXCL12) or PMA, an activator of protein kinase
C, enhanced binding of soluble monovalent ICAM-1, indicat-
ing afﬁnity upregulation (Schurpf and Springer, 2011). However,
artiﬁcially stabilizing speciﬁc LFA-1 structures resulted in ICAM-1
binding afﬁnities of the intermediate afﬁnity state that were sim-
ilar to those achieved by inside-out activation, and of the high
afﬁnity state that were much higher. In a novel assay in which
antibodies that speciﬁcally recognize extended LFA-1 conformers
(KIM127 mAb and NKI-L16 mAb) or the putative high afﬁn-
ity state of LFA-1 (327C mAb) were co-immobilized with the
chemokine CXCL12, it was found that peripheral blood lympho-
cytes bound only KIM127 and NKI-L16, but not 327C (Shamri
et al., 2005). These data all suggest that chemokines trigger LFA-1
extension, but cannot induce the full afﬁnity of the ligand-binding
headpiece.
If inside-out activation does not shift integrin afﬁnity to its
highest state, how then does ligand binding do so? The demon-
stration of a catch bond between LFA-1 and ICAM-1 provides
insight into a possible mechanism and also suggests an impor-
tant role for force in afﬁnity maturation of the αI domain (Chen
et al., 2010). Using a biomembrane probe to ligate single LFA-1
molecules and measure bond kinetics in the absence or presence
of a pulling force, Zhu and colleagues (Chen et al., 2010) demon-
strate that ICAM-1-occupied LFA-1 passes through three distinct
bond lifetime regimes with increasing force. Pulling on the bond
ﬁrst enhanced LFA-1 afﬁnity (catch bond) and then, for larger
forces, resulted in a decrease in bond lifetime (slip bond). They
propose that pulling on the αI domain results in its movement
away from the βI domain, causing the anchored (to the βIMIDAS)
α7 helix to experience a relative shift downward (as discussed
above) and resulting in afﬁnity upregulation of the αI domain
(Chen et al., 2010). Thus, in the context of physiologic leukocyte–
endothelial interactions in which LFA-1 bonds experience a force
from blood ﬂow acting on rolling or adherent cells, chemokines
may stimulate LFA-1 extension while enhancing afﬁnity of the
headpiece only moderately. Upon ICAM-1 engagement, the bond
would then undergo further afﬁnity maturation and transition
into the high afﬁnity conformation supporting long-lived bonds.
This model of force-mediated LFA-1 afﬁnity maturation also sug-
gests a role for cytoskeletal anchorage of the integrin tail (Alon
and Dustin, 2007; Zhu et al., 2008). Talin represents the best
candidate for mediating such actin linkage through sequences
in its rod domain (Critchley, 2009), though a speciﬁc role for
talin-mediated actin ﬁlament association in LFA-1 activation is
yet to be described. A potential role for Kindlins in mediat-
ing indirect cytoskeletal anchorage is also discussed below in
further detail.
REGULATION OF LFA-1 ACTIVATION IN NEUTROPHILS
Neutrophils play a central role in immunity as the ﬁrst leukocyte
subset to enter tissues in response to infection or injury. Inﬂamma-
tory cues produced locally in the tissue are relayed to neutrophils
through the expression of adhesion molecules, such as E-selectin
and ICAM-1, on the luminal surface of endothelial cells. This
induced expression of adhesion molecules initiates a cascade of
progressive interactions between leukocytes and the vascular wall
that precede transmigration across the endothelial barrier and into
the affected tissue (Ley et al., 2007).
Members of the β2 integrin family [Box 2], whose expression
is restricted to leukocytes and leukocyte-derived tissue cells, are
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involved at several steps of the leukocyte adhesion cascade. Ini-
tial capture and rolling of neutrophils is mediated primarily by
endothelial E- and P-selectins binding to P-selectin glycoprotein
ligand-1 (PSGL-1) and other selectin ligands on the surface of
neutrophils. In addition to its function as an adhesion receptor,
PSGL-1 transduces an intracellular signal that partially activates
LFA-1 (Zarbock et al., 2007b; Miner et al., 2008; Kuwano et al.,
2010; Figure 2). Although other leukocyte subsets, including some
memory T lymphocytes, express functional PSGL-1, it seems that
ligation of PSGL-1 triggers LFA-1 extension only in myeloid cells.
It may be that the lymphoid homologs of one or more molecules
downstream of PSGL-1 do not participate in this signaling path-
way (Alon and Ley, 2008). The molecular details of the signal
transduction pathway triggered by PSGL-1 engagement and lead-
ing to LFA-1 activation in neutrophils has been the subject of
recent reviews (Zarbock et al., 2009, 2011), and new details on
this signaling cascade continue to emerge (Stadtmann et al., 2011;
Block et al., 2012; Lefort et al., 2012; Shao et al., 2012; Spertini
et al., 2012). During neutrophil rolling interactions with P- and E-
selectin, PSGL-1 signaling results in the conversion of LFA-1 from
an inactive state to an extended conformation that then inter-
acts with ICAM-1 to reduce neutrophil rolling velocity (Chesnutt
et al., 2006; Zarbock et al., 2007b; Kuwano et al., 2010). Two main
pieces of evidencedemonstrate that the extendedLFA-1 conformer
with a closed headpiece mediates slow rolling in both murine
and human neutrophils. First, an LFA-1 allosteric antagonist that
binds to the βI domain and blocks structural communication
with the αI domain, thus preventing headpiece opening, com-
pletely abrogates soluble ICAM-1 binding (Shimaoka et al., 2003a)
and neutrophil arrest, but does not impair LFA-1-dependent
slow rolling (Zarbock et al., 2007b). Second, the KIM127 mAb
(Robinson et al., 1992) and NKI-L16mAb (van Kooyk et al., 1991)
epitopes that report extension of the β2 and αL legs, respectively,
are exposed in human neutrophils rolling on E-selectin in ﬂow
chambers (Kuwano et al., 2010). In the same assay, the mAb
24 (Dransﬁeld et al., 1992) recognition site that is only accessi-
ble in the high afﬁnity state remains buried unless neutrophils
are activated by Mn2+ (Kuwano et al., 2010). Thus, ligation of
PSGL-1 induces LFA-1 extension, but not (full) opening of the
headpiece.
Talin-1 Talin-1 Kindlin-3
ICAM-1E/P-selectin
PSGL-1
GAG
CXCL1
CXCR2
Endothelial cell
Rap1-GTP
CalDAG-GEFI
Fgr
FcRγ/DAP12
Syk
Btk PLCγ2
PI3Kγ
p38ADAP/SLP-76
Gαi2 Gβγ
PLCβ2/3
IP3 + DAG PI3Kγ
Ca2+?
FIGURE 2 | Neutrophil inside-out activation of LFA-1.Two distinct signal
transduction pathways modulate LFA-1 activation in neutrophils: (1) selectin
binding to PSGL-1, and (2) chemokine receptor engagement. PSGL-1 signals
talin-1-dependent LFA-1 extension, whereas chemokine GPCRs signal LFA-1
activation to a high afﬁnity state that requires both talin-1 and Kindlin-3. Some
of these signaling molecules may exist in preformed modules to facilitate
rapid integrin activation. Abbreviations: Fgr, feline Gardner–Rasheed sarcoma
kinase; FcRγ, immunoglobulin gamma Fc receptor; DAP12, DNAX activating
protein of 12 kDa; Syk, spleen tyrosine kinase; ADAP, adhesion and
degranulation promoting adaptor protein; SLP-76, SH2 domain-containing
leukocyte phosphoprotein of 76 kDa; Btk, Bruton tyrosine kinase; PI3K,
phosphoinositide 3-kinase; PLC, phospholipase C; p38, p38 mitogen activated
protein kinase; IP3, inositol trisphosphate; DAG, diacylglycerol; CalDAG-GEFI,
calcium- and diacylglycerol-regulated guanine nucleotide exchange factor I;
PSGL-1, P-selectin glycoprotein ligand-1; ICAM-1, intercellular adhesion
molecule-1; GAG, glycosaminoglycan.
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During inﬂammation, neutrophils encounter immobilized
chemokines as they roll on the vascular wall. LFA-1 is the pri-
mary integrin receptor involved in leukocyte arrest on inﬂamed
endothelium, with little or no detectable contribution of Mac-1
(Ding et al., 1999; Ley et al., 2007). SDF-1α (a ligand for CXCR4)
and chemokine ligands for CXCR2 trigger soluble ICAM-1
binding and rapid lymphocyte arrest on immobilized ICAM-1
(Constantin et al., 2000; Giagulli et al., 2004; Shamri et al., 2005;
Bolomini-Vittori et al., 2009). This has been interpreted to mean
that high afﬁnity LFA-1 is required to mediate leukocyte arrest.
Intravital microscopy analysis of the mouse cremaster muscle,
a thin tissue that envelops the testes, after intravenous injec-
tion of CXCL1 provides a sensitive arrest assay, as neutrophils
rapidly (within 15 s) transition from rolling to arrest on the
endothelium. This assay provides the ability to distinguish the
arrest step from adhesion stabilization, as neutrophils lacking sig-
naling molecules involved in the latter process, such as PI3Kγ
(Smith et al., 2006) and PKCθ (Bertram et al., 2012), quickly
detach and return to the bulk ﬂow. Since chemokine signaling
also contributes to the stabilization and strengthening of leuko-
cyte adhesion following arrest by enhancing LFA-1 mobility and
allowing clustering to occur (Constantin et al., 2000; Giagulli
et al., 2004, 2006), the analysis of rapid arrest in vivo is criti-
cal for assessing the functional role of molecules in inside-out
activation of LFA-1. CXCL1 (also known as keratinocyte-derived
chemokine) is the primary chemokine involved in murine neu-
trophil arrest through CXCR2 and activation of the Gαi2 signaling
cascade (Ley, 2003; Smith et al., 2004; Zarbock et al., 2007a).
In the context of inﬂammation, both the PSGL-1 and CXCR2
signaling pathways that regulate LFA-1 activation contribute to
neutrophil adhesion and recruitment (Smith et al., 2004; Zarbock
et al., 2007b). PSGL-1 signaling seems to induce only the extended
conformation of LFA-1, and even pulling on LFA-1 as it tran-
siently engages with ICAM-1 in slow rolling is not sufﬁcient
to induce rapid neutrophil arrest mediated by the high afﬁnity
conformation. By contrast, in the presence of chemokines, neu-
trophil LFA-1 reaches its high afﬁnity state and mediates arrest.
Another potential difference between these two signaling pathways
is that chemokine receptors trigger rapid and locally restricted
LFA-1 activation (Shamri et al., 2005), whereas PSGL-1 signals
to LFA-1 may not be as spatially conﬁned (Alon and Ley, 2008;
Kuwano et al., 2010). It has been proposed that the downstream
signaling proteins involved in integrin activation may be pre-
assembled into complexes, thus allowing for leukocyte arrest to
occur on the timescales observed experimentally (Alon and Ley,
2008). Consistent with this idea, a signaling module containing
SKAP55 (Src kinase-associated phosphoprotein of 55 kDa),ADAP
(adhesion and degranulation promoting adaptor protein), RIAM
(Rap1-interacting adaptor molecule), and Kindlin-3 exists consti-
tutively in unstimulated human T lymphocytes, and inducibly
associates with the common integrin activator Rap1 GTPase
(Kliche et al., 2012).
NEW MECHANISTIC INSIGHTS INTO INSIDE-OUT
LFA-1 ACTIVATION
LFA-1 has been a model for studying integrin activation for more
than 20 years. The role of inside-out signaling in regulating
LFA-1 structure and afﬁnity is a topic of great interest not only
in the ﬁelds of immunology and leukocyte adhesion, but also
among integrin biologists. Until recently, the roles of two fam-
ilies of common integrin co-activators, talins and Kindlins, in
regulating LFA-1 conformational activation had not been stud-
ied. Using mixed chimeric mice with genetic deletion of either
Fermt3 encoding Kindlin-3 or Tln1 encoding talin-1, we tested
the individual roles of these two proteins in neutrophil slow
rolling and arrest mediated by LFA-1 (Lefort et al., 2012). We rea-
soned that since different conformations of LFA-1 are induced
by stimulating either the PSGL-1 or CXCR2 signaling cascades, it
would be possible to separately test whether talin-1 and Kindlin-3
were involved in LFA-1 extension versus headpiece opening. We
observed that LFA-1-dependent neutrophil slow rolling on E-
selectin/ICAM-1 substrates in ﬂow chambers and on inﬂamed
endothelium in vivowas impaired in talin-1-deﬁcient neutrophils,
but was unaffected by knockout of Kindlin-3. In contrast, both
talin-1 and Kindlin-3 were required for CXCL1-stimulated rapid
neutrophil arrest and soluble ICAM-1 binding to LFA-1, indi-
cating an important role for these co-activators in reaching the
high afﬁnity state of LFA-1. Our ﬁndings in neutrophils were
corroborated by studies measuring LFA-1 afﬁnity states using
the reporter antibodies KIM127 (Robinson et al., 1992), NKI-
L16 (van Kooyk et al., 1991), mAb 24 (Dransﬁeld et al., 1992),
and 2E8 (Carreno et al., 2010) in human HL-60 cells stimu-
lated with an active Rap1a peptide. Together, these results show
that talin-1 is needed for LFA-1 extension, while Kindlin-3 is
involved in transition of the LFA-1 headpiece to its high afﬁn-
ity state. These data are the ﬁrst to demonstrate distinct functions
of talin-1 and Kindlin-3 in inducing speciﬁc conformers of LFA-1.
It remains to be shown whether talin-1 plays an additional role
in LFA-1 headpiece opening to reach the high afﬁnity state, or
whether LFA-1 extension is a prerequisite for headpiece opening
in the context of chemokine-induced neutrophil arrest. Further-
more, previous studies of cultured effector T lymphocytes derived
from LAD-III patients suggest that Kindlin-3 is needed for LFA-1
extension in the context of chemokine stimulation (Manevich-
Mendelson et al., 2009). It is apparent that there are diverse
mechanisms among the various modalities of integrin activation
in leukocytes.
What do these new insights into talin-1 and Kindlin-3 regula-
tion of LFA-1 structure tell us about themechanisms of inside-out
activation? It was not surprising to ﬁnd that talin-1 is needed
for LFA-1 extension. As shown for αIIbβ3 in a reconstituted
system, the talin head domain (but not intact, autoinhibited
talin) is sufﬁcient to induce extension of the integrin extracel-
lular domain (Ye et al., 2010). Several studies have shown that
talin directly disrupts the basal association of integrin TMDs by
contacting the salt bridge between the α and β chains close to
the inner membrane leaﬂet (Wegener et al., 2007; Anthis et al.,
2009). Talin is likely involved in further rearrangement of the
TMDs, as mutations that disrupt the α/β salt bridge do not
fully overcome the requirement for talin in integrin activation
(Tadokoro et al., 2003; Wegener et al., 2007). That Kindlin-3
was not required for neutrophil slow rolling mediated by the
extended/closed conformer of LFA-1 (Lefort et al., 2012) suggests
that itmaynot be involved in initial disruptionof the LFA-1TMDs.
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However, structural studies of LFA-1 suggest that the TMDs and
lower legs are separated even further in high afﬁnity than in inter-
mediate afﬁnity LFA-1 (Nishida et al., 2006). Thus, Kindlin-3
may be involved in inducing swingout of the hybrid domain
by causing a further separation of the TMDs. It is also possible
that Kindlin-3 mediates the indirect linkage of the β2 integrin
tail to the actin cytoskeleton through a scaffolding function,
thus providing an anchor for force-induced conversion of lig-
ated integrins to the high afﬁnity state. It was recently found
that LFA-1-mediated neutrophil slow rolling is not dependent
on the linkage of LFA-1 to the actin cytoskeleton (Shao et al.,
2012), but chemokine-stimulated arrest of lymphocytes (Shamri
et al., 2005) and neutrophils (Shao et al., 2012) is impaired by
reagents that disrupt actin microﬁlaments. These studies sup-
port the idea that LFA-1 extension and headpiece opening are
distinctly regulated processes, and that Kindlin-3 may be involved
in the transition to a high afﬁnity state through an indirect inter-
action with the actin cytoskeleton. Kindlins have been shown to
bind to several actin-binding proteins and complexes, including
integrin-linked kinase (Mackinnon et al., 2002),migﬁlin (Tu et al.,
2003), focal adhesion kinase, and α-actinin (Has et al., 2009).
The expression and role of these adaptor molecules in LFA-1
activation will need to be tested in leukocyte arrest under ﬂow
conditions.
The distinct roles of talin-1 and Kindlin-3 in neutrophil slow
rolling and arrest raise several questions about the two signal-
ing pathways that stimulate these separate behaviors. Clearly,
LFA-1 engages ICAM-1 during slow rolling interactions induced
by PSGL-1 signaling. If chemokines directly stimulate only LFA-1
extension and not conversion to the high afﬁnity state, why does
CXCR2 engagement lead to neutrophil behavior qualitatively dis-
tinct from the PSGL-1 pathway that has also been shown to
induce LFA-1 extension? Likewise, if force on the LFA-1/ICAM-1
bond results in afﬁnity maturation to the long-lived state, how
are neutrophils able to use LFA-1 for rolling interactions that
require a transient bond with a fast off-rate? Structural com-
munication between the βI and αI domains through the α7
helix is needed for headpiece opening (Shimaoka et al., 2003a).
Perhaps Kindlin-3 provides a permissive signal or induces a
structural rearrangement that allows coupling of the βI and αI
domains, such as swingout of the hybrid domain. We specu-
late that Kindlin-3 may be actively excluded from binding to the
β2 cytoplasmic tail after inside-out activation of LFA-1 by the
PSGL-1 signaling pathway and this prevents the transition to the
open headpiece and neutrophil arrest. This could occur by pro-
moting the binding of a competing molecule to the Kindlin-3
binding NPKF site on the β2 tail, or by regulating phospho-
rylation of threonine residues that also contribute to Kindlin-3
binding (Ma et al., 2008). Indeed, T cell receptor signaling affects
the phosphorylation of β2T758 and promotes binding of 14-3-3
proteins and LFA-1 activation (Fagerholm et al., 2005; Gronholm
et al., 2011). Whether this is also true for chemokine signaling
is unknown.
A potential alternative mechanism for LFA-1 extension result-
ing in distinct slow rolling and arrest behaviors after PSGL-1 and
CXCR2 signaling, respectively, may be that chemokines also stim-
ulate an increase in LFA-1 mobility in the membrane (Constantin
et al., 2000) that could lead to ligand-driven LFA-1 clustering and
subsequent ﬁrm adhesion. This mechanism would require that
LFA-1 ligands like ICAM-1 are pre-clustered on endothelial cells
(Barreiro et al., 2008), because integrin clustering is most likely a
post-ligand binding event (Kim et al., 2004). In the case of slow
rolling, if LFA-1 is immobile following PSGL-1 engagement then
clustering may be disfavored and the force on individual LFA-1/
ICAM-1 bonds could be sufﬁciently high so that LFA-1 resides in
the slip bond regime with short enough lifetimes (high koff ) to
support rolling behavior. Clearly, much remains to be tested to
uncover the mechanisms regulating LFA-1 structure and afﬁnity
on the surface of leukocytes.
CONCLUDING REMARKS
LFA-1plays important roles in the trafﬁcking ofmultiple leukocyte
subsets during the immune response. At least two distinct signal-
ing pathways impact the adhesive function of LFA-1 by altering its
structure, and thus afﬁnity for extracellular ligands. Post-ligand
binding LFA-1 clustering alters its distribution on the plasma
membrane. Our understanding of how cellular factors regulate
LFA-1 conformation by binding to its short cytoplasmic tails has
evolved as Kindlin-3 and talin-1 have been identiﬁed as major
and distinct players. The concepts explaining how structural rear-
rangements are propagated through the TMDs and integrin legs
to the ligand-binding headpiece are being reﬁned. It has recently
become clear that force plays an integral role in these processes, and
future work will be aimed at determining the molecular require-
ments and mechanisms of LFA-1 afﬁnity regulation by force in
rolling and arresting leukocytes.
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